[Prolonged treatment with prednisone and azathioprine in chronic hepatitis with immunological disorders].
D000293:Adolescent; D000328:Adult; D045930:Anabolic Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use*; D004044:Dietary Proteins / Q000627:therapeutic use; D005260:Female; D006505:Hepatitis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007154:Immune System Diseases / Q000209:etiology*; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*
D045930:Anabolic Agents; D004044:Dietary Proteins; D001379:Azathioprine; D011241:Prednisone
Tratament prelungit cu prednison şi azatioprină în hepatite cronice cu perturbări imunologice